Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom’s macroglobulinaemia in Sweden

References

• Kristinsson SY, Bjorkholm M, Goldin LR, et al. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. Blood. 2008;112:3052–3056.
   PubMed Web of Science ®Google Scholar
• Treon SP, Hunter ZR, Aggarwal A, et al. Characterization of familial Waldenstrom's macroglobulinemia. Ann Oncol. 2006;17:488–494.
   PubMed Web of Science ®Google Scholar
• Koura DT, Langston AA. Inherited predisposition to multiple myeloma. Ther Adv Hematol. 2013;4:291–297.
   PubMedGoogle Scholar
• Wang H, Chen Y, Li F, et al. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer. 2012;118:3793–3800.
   PubMed Web of Science ®Google Scholar
• Iwanaga M, Chiang CJ, Soda M, et al. Incidence of lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003. Int J Cancer. 2014;134:174–180.
   PubMed Web of Science ®Google Scholar
• Greenberg AJ, Vachon CM, Rajkumar SV. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012;26:609–614.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Landgren O, McMaster ML, et al. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: the InterLymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014:87–97.
   PubMedGoogle Scholar
• Baecklund E, Smedby KE, Sutton LA, et al. Lymphoma development in patients with autoimmune and inflammatory disorders–what are the driving forces? Semin Cancer Biol. 2014;24:61–70.
   PubMed Web of Science ®Google Scholar
• Brandefors L, Kimby E, Lundqvist K, et al. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies – a population-based study from northern Sweden. Acta Oncol. 2016;55:91–98.
   PubMed Web of Science ®Google Scholar
• Preuss KD, Pfreundschuh M, Ahlgrimm M, et al. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. Int J Cancer. 2009;125:656–661.
   PubMed Web of Science ®Google Scholar
• Grass S, Preuss KD, Wikowicz A, et al. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. Blood. 2011;117:2918–2923.
   PubMed Web of Science ®Google Scholar
• Grass S, Preuss KD, Pfreundschuh M. Autosomal-dominant inheritance of hyperphosphorylated paratarg-7. Lancet Oncol. 2010;11:12.
   PubMed Web of Science ®Google Scholar
• Preuss KD, Fadle N, Regitz E, et al. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits. Int J Cancer. 2014;135:2046–2053.
   PubMed Web of Science ®Google Scholar
• Grass S, Iida S, Wikowicz A, et al. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma. Cancer Sci. 2011;102:565–568.
   PubMed Web of Science ®Google Scholar
• Zwick C, Held G, Auth M, et al. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM. Int J Cancer. 2014;135:934–938.
   PubMed Web of Science ®Google Scholar
• Grass S, Preuss KD, Ahlgrimm M, et al. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. Lancet Oncol. 2009;10:950–956.
   PubMed Web of Science ®Google Scholar
• Brandefors L, Melin B, Lindh J, et al. Prognostic factors and primary treatment for Waldenström macroglobulinemia - a Swedish Lymphoma Registry study. Br J Haematol. 2018;183:564–577.
   PubMed Web of Science ®Google Scholar
• Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005;97:199–209.
   PubMed Web of Science ®Google Scholar
• Grass S, Preuss KD, Thome S, et al. Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM. Blood. 2011;118:635–637.
   PubMed Web of Science ®Google Scholar